News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
Are you interested in making an impact on the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibility? The National Institute of Allergy and Infectious Diseases (NIAID), Technology Transfer and Intellectual
The 17th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer will be held on Friday, September 25, 2024 at 10 a.m. ET in the Masur Auditorium in Building 10. The Chen lecture was established in 2006 by the NIH Deputy Director for Intramural Research and the
MedInvest is hosting a Biotech and Pharma Investor Conference September 18-19, 2024 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is